CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility Study

Grants and Contracts Details

StatusActive
Effective start/end date5/7/201/11/27

Funding

  • CorMatrix Cardiovascular Incorporated: $59,157.00